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The Outcome of 
Kidney Retransplantation 
Bo S. Husberg, MD, Thomas E. Starzl, MD, PhD, Denver 
The survival of 66 patients with retrans- 
planted kidneys, from August 1963 to March 
1973, was evaluated. The life expectancy af- 
ter retransplantation is less than that after 
primary transplantation but the difference is 
mainly due to an increased early postopera- 
tive mortalify. The prognosis after retrans- 
plantation is greatly improved if the second 
kidney is from a related donor. The progno- 
sis is likewise improved if a longer period of 
time has elapsed between the two transplan- 
tations. Surprisingly, prwious exposure to 
specific HL-A antigens does not worsen the 
prognosis for a subsequent transplanted kid- 
ney. 
M ost dialysis centers have an excessive number of uremic pa- 
tients. Since patients who have re- 
jected their transplanted kidneys add 
significantly to the pool of dialysis 
cases, i t  is an important question 
whether, and a t  what time, retrans- 
plantation should be carried out. A 
number of publications have implied 
that  the results after  retransplanta- 
tion are equivalent to those following 
a first procedure.'-'I This has not been 
our experience, as documented in this 
report of patient and kidney survival 
after retransplantation. An analysis 
is also presented of the contribution 
to the outcome of other factors, such 
as HL-A mismatch, time of retrans- 
plantation in relation to time of first 
transplantation, cause of primary 
graft  failure, and original kidney dis- 
ease. 
Clinical Population 
At our transplantation unit, 66 patients 
receiving their first renal homografts b e  
tween November 1962 and August 1972 
have later undergone one to four retrans- 
plantations. Follow-up data are available 
from a few months to more than nine 
years after the retransplantations. The im- 
munosuppressive treatment after retrans- 
plantation was frequently different from 
that used intially, since the therapy pro- 
vided was dependent on the management 
currently under evaluation for new cases.' 
Also, if the patients had received ALG ear- 
lier, they usually did not receive it after 
retransplantation. About half of the pa- 
tients underwent retransplantation with- 
out removal of the previous graft and 
without a period of dialysis prior to re- 
grafting.' 
Results 
Accepted for publication Dec 6, 1973. 
From the Department of Surgery, Denver The retrans- 
Veterans Administration Hospital and the Uni- plantation with our 66 patients is 
versity of Colorado Medical Center. Denver. 
Read before the 81st annual meeting of the summarized in Fig 1. More than one 
Western Surgical Association, Houston, Nov 17, half (35 of 66) have been followed UP 
1973. for more than five vears from the 
Reprint requests to the Department of Sur- 
gery, University of Colorado Medical Center, time their primary transplantam 
4200 E 9th St, Denver 50220 (Dr. Husberg). tion. The life survival, using the time 
of the first transplantation as the 
starting point, was superior a t  all 
subsequent levels of follow-up to that 
when the date of retransplantation 
was accepted as the starting basis for 
calculation. The main difference in 
survival was due to a heavier mortal- 
ity in the first three months after r e  
transplantation than during the com- 
parable period after the primary 
grafting. This mortality was not a 
function of whether homograft ne- 
phrectomy and interval dialysis was 
elected versus prompt retransplanta- 
tion, leaving a failing graft  in situ 
without discontinuance of immuno- 
suppression. By the end of three 
months, in cases of retransplantation, 
there was a gap of almost 20% and, 
subsequently, the differential r e  
mained about the same (Fig 1). 
The survival after  secondary trans- 
plantation was somewhat influenced 
by the kind of kidney that  was used 
a t  the first transplantation (Fig 2). If 
the first kidney was from a related 
donor, the overall five-year survival 
after the first transplant was 15 of 27 
patients (56%), but after the second 
transplantation, the survival after 
five years, calculated from the time 
of retransplantation, was only 21% 
(three of 14 patients). The poor * 
sults were a t  least partly attributed 
to a heavy reliance on cadaveric kid- 
neys for retransplantation. 
When the primary kidney came 
from an unrelated donor, the early 
584 Arch Surg/Vol 108, April 1974 
IS- 
ed 
ed 
If 
ed 
ral 
27 
nd 
;er 
ne 
1% 
re- 
;ed 
id- 
pa:ient survival after retransplanta- 
tion was less than that after primary 
transplantation, but the later sur- 
vi\-a1 figures were similar. I t  is note- 
worthy that three of the 21 recipients 
wcAre given kidneys from related do- 
nors the second time; after m&e than 
five years following retransplanta- 
tion, all three are well. 
As implied, the source of the sec- 
ondary kidney graft was profoundly 
influential in determining subsequent 
patient survival (Fig 3). When the or- 
gans could be obtained from related 
donors, the results, while not as good 
as for the primary consanguineous 
transplantations, represented a sur- 
vival better than 50% for five years. 
In contrast, recipients of unrelated 
(usually cadaveric) kidneys for re- 
transplantation had a much poorer 
long-term prognosis. In this latter 
category, none cf 12 patients has sur- 
vived four years. 
The time between first and second 
transplantation influenced the kidney 
sunrival after the second transplanta- 
tion (Fig 4). The kidney survival was 
better the longer the time between 
the two graft  procedures. 
The kidney survival with and with- 
out knqwn specific HL-A presen- 
sitization is shown in Fig 5. There 
were 65 grafts that, on the basis of 
the antigens then identifiable, did not 
share HL-A antigens with a previ- 
ously rejected transplant, and 18 
grafts in which one (17 cases) or two 
(one case) antigens, clearly present in 
a nonprimary donor and foreign to  
the recipient, had been present in a 
donor of a previous transplant. The 
differences in results were not differ- 
ent in a statistically significant way, 
but if anything, i t  was possibly 
slightly advantageous to have had an 
HL-A presensitization. The HL-A an- 
tigens involved in the cases of pre- 
sensitization were as follows: A2 in 
seven cases; A1 in three cases; A12 in 
two cases; and A3, A7, A10, A l l ,  W 17, 
W27, and Te60 in one case each (Tera- 
saki nomenclature). 
An attempt was also made to ana- 
lyze whether either the cause of the 
first graft failure or the original dis- 
ease of the patients influenced the re- 
sults. These attempts proved unre- 
warding in the first instance because 
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Fig 1.-Numerators and denominators indicate patients surviving and patients at risk, re. 
spectively, during each time period (follow-up to Aug 1. 1973). 
Fig 2.-Top, Survival of 45 patients with retransplanted kidneys after first related grafts 
had failed. Bottom, Survival of 21 patients with retransplanted kidneys after first unrelated 
transplants were rejected. Numerators and denominators as in Fig 1 (follow-up to Oct 1, 
1973). 
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(negative cross-match). In spite of the five 
weeks presensitization to H L A  antigens 
A2 and A7, the second kidney has func- 
tioned well until now. In July 1972, the 
first graft was removed, 15 months after 
its insertion, because of vague pain in the 
pneral area of the graft and poor kidney 
perfusion as determined by renal scan. On 
histopathologic examination, the kidney 
was found to be rejected. 
Comment 
I t  appears that  the outcome of re- 
transplantation in a group of patients 
having rejected their first grafts  is 
worse than that after  primary trans- 
plantation, but not to  a great  degree. 
The difference is mainly accounted 
for by an increased early postopera- 
tive mortality. I t  is an important and 
interesting practical consideration 
that such ~ a t i e n t s  also have a sub- 
stantially depreciated prognosis if 
they are returned to long-term hemo- 
dialysis." 
The type of kidney used primarily 
has not been considered an overriding 
factor in the decision of whether or 
not to perform a retransplantation. I t  
has been considered justified to use 
kidneys of relatives for retransplanta- 
tion if such are available. as the sub- 
sequent result has been superior to 
that wikh secondary cadaveric kid- 
neys. The prognosis after  retrans- 
plantation has been better if a long 
period of time elapsed after  first 
transplantation. ~ o s s i b l ~  a long unin- 
terrupted period of immunosuppres- 
sive treatment makes the recipient 
better able to accept a second trans- 
plant. Alternatively, patients who 
have b o n e  chronically functioning 
homografts without dramatic, acute 
rejection episodes may represent a 
favorable subpopulation that  has 
been refined by natural selection. 
Specific HL-A presensitization i n  
the absence of positive direct cross- 
match does not contraindicate a re- 
transplantation procedure. This could 
Transplantotion with known specific HLA 
presensit izat ion from a previous kidney 
gra f t  (kidney survival, 18 kidneys) 
Transplantotion without known specific HLA 
prasensitization from a previous kidney 
graft  (kidnay survival. 65 kidneys) 
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Fig 5.-Numerators and denominators indicate kldneys funct~onlng and kidneys at risk 
during each time period (follow-up to Oct 1, 1973). 
be construed as further evidence of MD; Torben Johansen, MD; Israel Penn, MD; and 
the now well accepted poor dis- W. Putnam* MD. 
crimination of HL-A matching in 
predicting the outcome after  organ References 
transplantation.' Or if HL-A anti- 
gens are directly related to histocom- 
patibility, there is even a possibility 
that  specific blocking antibodies were 
produced as a response to the sensi- 
tizing antigen, since the results, if 
anything, were slightly better if 
there had been prior exposure to an  
HL-A antigen found in a nonprimary 
donor. 
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